LUNDBECK PHARMA A/S — Credit Rating and Financial Key Figures

LUNDBECK PHARMA A/S (CVR number: 56750215) is a company from KØBENHAVN. The company reported a net sales of 18.3 mDKK in 2024, demonstrating a growth of 14.9 % compared to the previous year. The operating profit percentage was at 15.5 % (EBIT: 2.8 mDKK), while net earnings were 1820 kDKK. The profitability of the company measured by Return on Assets (ROA) was 16.1 %, which can be considered excellent and Return on Equity (ROE) was 60.5 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 17.8 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. LUNDBECK PHARMA A/S's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.